• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Product › Details

therapeutic antibody

	Next higher product group	antibody

Record changed: 2019-08-30

Advertisement

More documents for therapeutic antibody

• [1] Adrenomed AG. (8/29/19). "Press Release: Adrenomed Supervisory Board Appoints Jens Schneider-Mergener as CEO and Jens Zimmermann, CMO, Joins the Executive Board". Hennigsdorf....
• [2] HiFiBio Therapeutics. (8/28/19). "Press Release: HiFiBio Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders". Cambridge, MA, Shanghai & Paris....
• [3] Adrenomed AG. (8/13/19). "Press Release: Adrenomed AG Takes Part in Four Upcoming Conferences". Hennigsdorf....
• [4] Yumab GmbH. (7/22/19). "Press Release: Yumab Announces New Research and Collaboration Agreement with Merck". Braunschweig....
• [5] Novartis AG. (7/16/19). "Press Release: FDA Accepts File and Accelerates Review of Novartis Sickle Cell Disease Medicine Crizanlizumab (SEG101)". Basel....
• [6] IGM Biosciences, Inc.. (7/8/19). "Press Release: IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline"....
• [7] Citryll B.V.. (7/3/19). "Press Release: Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody". Oss....
• [8] GlaxoSmithKline plc. (7/3/19). "Press Release: GSK Announces Phase III Start for Its anti GM-CSF Antibody, Otilimab, in Patients with Rheumatoid Arthritis (RA)". London....
• [9] MorphoSys AG. (7/3/19). "Press Release: MorphoSys' Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab (MOR103/GSK3196165) in Rheumatoid Arthritis; MorphoSys Updates its Financial Guidance for 2019". Planegg....
• [10] Velabs Therapeutics GmbH. (6/27/19). "Press Release: Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme". Heidelberg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.